Striatal astrocytes engulf dopaminergic debris in Parkinson's disease: A study in an animal model

PLoS One. 2017 Oct 13;12(10):e0185989. doi: 10.1371/journal.pone.0185989. eCollection 2017.

Abstract

The role of astrocytes in Parkinson's disease is still not well understood. This work studied the astrocytic response to the dopaminergic denervation. Rats were injected in the lateral ventricles with 6-hydroxydopamine (25μg), inducing a dopaminergic denervation of the striatum not accompanied by non-selective tissue damage. The dopaminergic debris were found within spheroids (free-spheroids) which retained some proteins of dopaminergic neurons (e.g., tyrosine hydroxylase, the dopamine transporter protein, and APP) but not others (e.g., α-synuclein). Free-spheroids showed the initial (LC3-autophagosomes) but not the late (Lamp1/Lamp2-lysosomes) components of autophagy (incomplete autophagy), preparing their autophagosomes for an external phagocytosis (accumulation of phosphatidylserine). Free-spheroids were penetrated by astrocyte processes (fenestrated-spheroids) which made them immunoreactive for GFAP and S100β, and which had some elements needed to continue the debris degradation (Lamp1/Lamp2). Finally, proteins normally found in neurons (TH, DAT and α-synuclein) were observed within astrocytes 2-5 days after the dopaminergic degeneration, suggesting that the intracellular contents of degenerated cells had been transferred to astrocytes. Taken together, present data suggest phagocytosis as a physiological role of striatal astrocytes, a role which could be critical for cleaning striatal debris during the initial stages of Parkinson's disease.

MeSH terms

  • Animals
  • Astrocytes / drug effects
  • Astrocytes / metabolism*
  • Disease Models, Animal
  • Dopamine / metabolism*
  • Male
  • Neostriatum / drug effects
  • Neostriatum / pathology*
  • Oxidopamine / pharmacology
  • Parkinson Disease / pathology*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Oxidopamine
  • Dopamine

Grants and funding

This work was supported by the Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain (PI2014/06) to Manuel Rodriguez. The authors declare no competing financial interests.